-
ANH News Beat (week 12/2023)
23 March 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 9/2023)
02 March 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Nano-sized food additives may be harming your gut
30 March 2023
Why you should avoid foods, supplements and even drugs containing titanium and silicon dioxide
News / Food4Health Campaign / Health / Food / Campaigns
-
FEATURE: Frequency Medicine (Part 2) - Devices: Wacky or Worthy?
01 February 2023
Rob Verkerk PhD’s second part of his evaluation of frequency medicine, this time diving deep into devices that measure or deliver frequencies to the body
-
Learn & Journey: ANH events (week 47/2022)
23 November 2022
Upcoming events, conferences and available courses
-
Are you up for taking Big Pharma's new 'skinny' jab?
16 March 2023
After a succession of Big Pharma failures for anti-obesity drugs, will Novo Nordisk's latest offering, that emerges from something of a dark cloud, be just another side effect ladened sticking plaster, or a boon for users and a cash cow for its manufacturer?
-
Learn & Journey: ANH events (week 45/2022)
09 November 2022
Upcoming events, conferences and available courses
-
FEATURE: Don’t trust their plan to rebuild our trust in science
02 March 2023
The elimination of dissent and the marginalisation of scientists sceptical of the establishment’s scientific and medical agenda will destroy the scientific process - unless reversed. Find out how the concept of ‘scientific misinformation’ has been deliberately spun to make it the primary weapon aimed at protecting the interests of the status quo. As well as what we can do about it.
News / ANH Covid Zone / Health / Campaigns / Activism
-
Learn & Journey: ANH events (week 44/2022)
02 November 2022
Upcoming events, conferences and available courses
-
Regulatory limbo: the case of NAC
13 April 2023
The more effective a natural product, the greater the risk if it sits in an uncertain, regulatory ‘no man’s land’